1 / 23

Release of the EudraVigilance Data Warehouse and Analysis System (EVDAS) to National Competent Authorities in Member Sta

Release of the EudraVigilance Data Warehouse and Analysis System (EVDAS) to National Competent Authorities in Member States. Stefano Cappe Pharmacovigilance and Post-Authorisation Safety and Efficacy of Medicines EMEA, EU. Summary. EVDAS Release of EVDAS to NCAs Functionalities included

base
Download Presentation

Release of the EudraVigilance Data Warehouse and Analysis System (EVDAS) to National Competent Authorities in Member Sta

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Release of the EudraVigilance Data Warehouse and Analysis System (EVDAS) to National Competent Authorities in Member States Stefano Cappe Pharmacovigilance and Post-Authorisation Safety and Efficacy of Medicines EMEA, EU

  2. Summary • EVDAS • Release of EVDAS to NCAs • Functionalities included • Training of NCAs • Next steps

  3. EVDAS (I) • The EudraVigilance Data Analysis System is a database for: • Answering pharmacovigilance queries • Collecting and integrating data from a variety of Source Systems • Containing cleaned and consolidated data • Preserving historical data

  4. Adverse Reactions (ICSRs) EudraVigilance Data Warehouse Medicinal Products (EVMPD) User and Organisations MedDRA and Standard Terminology EVDAS (II) Data Analysis ETL Data Collection – Source systems

  5. Release of EVDAS to NCAs • The system has been released in July 2007 to: • EMEA internal users • National Competent Authorities (NCAs)

  6. EVDAS functionalities • Administrative queries • Number of ICSRs transmitted • Expedited reporting timelines

  7. EVDAS functionalities • Pharmacovigilance queries • Drug/Reaction Reports • Static PRR Reports • Dynamic PRR Reports • Reaction Monitoring Reports • Clinical Trials Reports • Patient Age/Sex Reports • MedDRA Dictionary Reports • Product Dictionary Reports

  8. Number of ICSRs transmitted Safety report received monthly by EMEA (PM top – CT bottom)

  9. Expedited reporting timelines - NCAs Reference period 1 April 2007 - 30 September 2007

  10. Expedited reporting timelines - MAHs Reference period 1 April 2007 - 30 September 2007

  11. Drug-reaction report This report is used to check the frequency of drug/reaction combinations in EVDAS

  12. Static PRR reports Signal highlighted for: PRR 95% LB >1 & COUNT>=3 Signal highlighted for: PRR>2 & CHI^2>4 & COUNT>=3

  13. Static PRR report (graph) Signal highlighted if the box is all included in the area marked in yellow

  14. Static PRR report (MedDRA) Calculation of PRR performed jointly at all levels of the MedDRA hierarchy Signal highlighted for: PRR 95% LB>1 & COUNT>=3

  15. PRR Dynamic Signal highlighted if the lower line (PRR 95% LB) enters in area marked in yellow

  16. New Start Monitoring Today Reaction monitoring report A reaction is displayed in the report only if a new ICSR is received in the monitoring period (“New”)

  17. It is possible to drill to the list of reactions in the trials Clinical Trial Monitoring Monitoring of clinical trials ongoing by EUDRACT Number

  18. Patient Age/Sex Reports Number of cases (y – axis) by age (x – axis) grouped by sex

  19. MedDRA Dictionary Reports It works as a MedDRA browser in EVDAS, it also allows to browse the Standard MedDRA Queries (SMQs)

  20. Training of NCAs • Users need to receive appropriate training before accessing EVDAS • Training of NCAs is ongoing: • 4 training courses have been organised (status 1st October 2007) • 55 NCA users have been trained

  21. Next Training Dates • Next training dates available for NCAs: • 8 – 10 October • 22 – 24 October • Training dates for Marketing Authorisation Holders will be planned once the Access Policy in EudraVigilance has been approved and implemented in EVDAS

  22. Next steps • Access to MAHs/Healthcare Professionals/General public • Additional Analyses • Stratification Analysis for PRR • Medicinal product interactions • Integration of Risk Management Plans • Integration of Signal Tracking Tool

  23. Questions?

More Related